Page 3 - Nirma Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GLS acquisition propels Nirma s pharma business into next phase of growth, says MD Hiren Patel

GLS acquisition propels Nirma s pharma business into next phase of growth, says MD Hiren Patel
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Stericon pharmaKarsanbhai patelDhiren patelNirma groupGlenmark life sciencesKhaitan coGlenmark pharmaceuticalsActive pharmaceutical ingredient

Nirma agrees to acquire 75 per cent stake in Glenmark Life Sciences at an enterprise value of about Rs 7,500 crore

Nirma agrees to acquire 75 per cent stake in Glenmark Life Sciences at an enterprise value of about Rs 7,500 crore
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.

Karsanbhai patelDhiren patelNirma groupGlenmark life sciencesKhaitan coGlenmark pharmaceuticalsGlenmark life sciences limitedGlenmark pharmaceuticals limitedActive pharmaceutical ingredientStericon pharma private limitedLife sciences limitedManaging directorNirma limitedSoda ashEast india

Nirma agrees to acquire 75% stake in Glenmark Life Sciences: Best Media Info

Nirma agrees to acquire 75% stake in Glenmark Life Sciences: Best Media Info
bestmediainfo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bestmediainfo.com Daily Mail and Mail on Sunday newspapers.

Stericon pharmaKarsanbhai patelDhiren patelBestmediainfo bureau delhiGlenmark life sciencesBestmediainfo bureauNirma groupGlenmark pharmaceuticalsKhaitan coMediainfo bureau delhiGlenmark pharmaceuticals limitedActive pharmaceutical ingredientLife sciencesManaging director

Nirma to buy majority stake in Glenmark Life Sciences

The transaction is subject to customary closing conditions precedent, including receipt of regulatory and shareholder approvals, added the release. Pursuant to the transaction, Nirma Limited will make a mandatory open offer to all public shareholders of GLS. The other contender Sekhmet Pharmaventures, a platform backed by, PAG, CX Partners and Samara Capital, did not put in their final offer after intense negotiations, ET reported.

Samarskaya oblastKarsanbhai patelGlenmark pharmaLafarge holcimStericon pharmaSekhmet pharmaventuresAculife healthcare pvt ltdGlenmark pharmaceuticals ltdGlenmark life sciencesAculife healthcare ltdOffering collegeNirma groupGlenmark pharmaceuticalsHealthcare management analytics programmeGlenmark life sciences to nirmaIndian school of business

Nirma agrees to acquire 75% stake in Glenmark Life Sciences at an Enterprise Value of about INR 7,500 Crore

Mumbai: In a successful bid, Nirma Group has entered into definitive agreement to acquire 75% of Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited at an enterprise value of about INR 7,500 Crore, subject to closing adjustments. Nir

Dhiren patelKhaitan coGlenmark pharmaceuticalsNirma groupGlenmark life sciencesGlenmark life sciences limitedGlenmark pharmaceuticals limitedActive pharmaceutical ingredientStericon pharma private limitedLife sciences limitedManaging directorNirma limited